JSM2026
Back to all people

Johannes Krisam

Boehringer Ingelheim
1 appearance in the program

Sessions & presentations

Rethinking Randomization: Bias, Ethics, and the Future of Clinical Trial Design.
Presentation: How the Chosen Randomization Method Affects the Individual Clinical Trial Participant.
Invited Paper Session · Sun, Aug 2 , 2:00 PM
Speaker